Bradmer Pharmaceuticals Inc. (TSE:GLX) Given Average Recommendation of “Buy” by Brokerages

Shares of Bradmer Pharmaceuticals Inc. (TSE:GLX) have been given an average rating of “Buy” by the eight research firms that are presently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, one has issued a buy recommendation and five have assigned a strong buy recommendation to the company.

A number of equities research analysts have recently weighed in on the stock. ATB Cormark Capital Markets lowered shares of Bradmer Pharmaceuticals from a “strong-buy” rating to a “moderate buy” rating in a report on Thursday, February 5th. Citizens Jmp raised Bradmer Pharmaceuticals to a “strong-buy” rating in a research report on Tuesday, December 9th. Finally, Citigroup raised Bradmer Pharmaceuticals to a “hold” rating in a research report on Tuesday, February 24th.

Bradmer Pharmaceuticals Price Performance